HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea

HCID 26328
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
13909-02-9
Standard SMILES
O=NN(CCCl)C(=O)NC1CCC(=O)NC1=O
InChIKey
KHWIRCOLWPNBJP-UHFFFAOYSA-N
Molecular formula
C8H11ClN4O4
Average molar mass
262.65 g/mol
Monoisotopic mass
262.0468825

Overview

PCNU is a chloroethylnitrosourea compound and an alkylating agent with antineoplastic property. PCNU inhibits DNA synthesis by alkylating DNA and causing DNA cross links, thereby inducing apoptosis. In addition, this agent may be associated with pulmonary, hepatic, and hematologic toxicities. Unlike other nitrosoureas, PCNU has strong alkylating while weak carbamoylating activity.

Names & identifiers

Preferred name
1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
IUPAC
1-(2-chloroethyl)-3-(2,6-dioxopiperidin-3-yl)-1-nitrosourea
English name
1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea
Molecular formula
C8H11ClN4O4
Molecular weight
262.65034

Names & synonyms

1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea13909-02-9NSC-95466NSC-95,466UNII-AZW59V4Q3BUrea, N-(2-chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitroso-AZW59V4Q3BNSC 95466BRN 0431046N-(2-Chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitrosoureaUrea, 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitroso-AI3-52898
Show more names
1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosoureaRefChem:74109Urea, N-(2-chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitroso-(9CI)PCNUNSC954661-(2-Chloroethyl)3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaCHEMBL12200SCHEMBL845062

Database identifiers

CAS
13909-02-9
PubChem CID
26328
DTXSID
DTXSID10864453
ChEMBL
CHEMBL12200
UNII
AZW59V4Q3B
Nikkaji
J15.712K

Properties

Computed structural properties

XLogP
0.4
Topological polar surface area
108 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
3
Heavy atoms
17
Formal charge
0
Complexity
348

Experimental & physicochemical properties

LogP0.37
Solubility · 6 items

Water < 1 (mg/mL)

Water pH 4 < 1 (mg/mL)

Water pH 9 2-3 (mg/mL)

10% EtOH < 1 (mg/mL)

95% EtOH 2-3 (mg/mL)

McOH 3-4 (mg/mL)

Stability/Shelf Life · 1 item

Bulk: A sample stored at 60° C for 10 days decomposed 18% (UV). The compound was found to be stable in bulk form at room temperature exposed to lab light through 60 days (UV, TLC and ionic chloride). For long -term storage the bulk compound should be protected from moisture and stored at -15° C. Solution: The compound dissolved in 3% methanol/ water decomposed 4% in one hour, 6.5% in three hours 15% in six hours, and 38% in 24 hours (UV). There was no formation of ionic chloride during the 24 hours. Solutions should be prepared immediately before use.

Physicochemical properties

Density
1.8525 · 1.8525 (rough estimate)
refractive index
1.6 · 1.6000 (estimate)
FDA UNII
59 V4Q3B · AZW59V4Q3B

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Toxicity Data · 4 items

Mouse(po): LD50 35700 lug/kg

Mouse(iv): LD50 22 mg/kg

Dog(iv): LDLo, 3 mg/kg

Monkey(iv): LDLo 10 mg/kg

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 1 item

A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes